Genome Insight Draws $23 Million in Series B Funding to Open the Whole Genome Era for Transforming Precision Medicine

Anke Neustadt

Funds will be allocated to accelerate rapid production and high-end curation of whole genome sequences for its clinical application SAN DIEGO, April 30, 2022–(BUSINESS WIRE)–Genome Insight, a global leader in Whole Genome Sequence analysis and interpretation, announced $23 million in Series B funding. Dunamu & Partners led the financing with […]

The Health Benefits of Acupuncture

Anke Neustadt

When the opioid addiction crisis began to surge in the U.S. about a decade ago, Dr. Medhat Mikhael spent a lot of time talking to his patients about other ways to heal pain besides opioids, from other types of medications to alternative treatments. As a pain management specialist at MemorialCare […]

FDA Grants Regenerative Medicine Advanced Therapy (RMAT) Designation to AlloVir’s Posoleucel for Prevention of Multiple Life-Threatening Infections from Six Viruses in Allogeneic Hematopoietic Cell Transplant Patients

Anke Neustadt

Posoleucel’s third RMAT designation marks an unprecedented regulatory distinction among cell and gene therapies Global Phase 3 multi-virus prevention trial initiated in March 2022 and is enrolling patients WALTHAM, Mass., April 20, 2022–(BUSINESS WIRE)–AlloVir (Nasdaq: ALVR), a late clinical-stage allogeneic T cell immunotherapy company, today announced that the U.S. Food […]